
April 15, 2026
A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.
Read more →
Sign-up for the Weekly Newsletter from Durham Reporter.